US42225T1079
US42225T1079
Health Catalyst, Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 133.2M EUR | 148.45M EUR | 93.66M EUR | 172.15M EUR |
Enterprise Value | 198.24M EUR | 257.84M EUR | 204.37M EUR | 292.57M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 236x | -- | -- | -- |
Price to Sales | 0.46x | 0.51x | 0.31x | 0.74x |
Price to Book | 1.31x | 1.47x | 0.68x | 0.7x |
EV/Revenue | 0.68x | 0.88x | 0.68x | 1.26x |
EV/EBITDA | 16.84x | 12.18x | 8.16x | 15.01x |
Price to FCF (P/FCF) | -- | 22.66x | -- | -- |
EV/FCF | -- | 39.36x | -- | -- |
FCF Yield | -36.52% | 4.41% | -2.94% | -9.16% |